Award
NIH Reporter #5R01NS123808-05
Retroviral RLI immunomodulatory gene therapy for glioblastoma
Recipient
University of California, San Francisco
Award Amount
$403,750.00
Ceiling
$403,750.00
Awarded
August 21, 2026
Identifier
5R01NS123808-05
Award for research on retroviral immunomodulatory gene therapy targeting glioblastoma, managed by UCSF, focusing on enhancing T-cell responses and overcoming resistance using advanced technologies.
Description
The project involves investigating retroviral delivery of immunomodulatory genes for glioblastoma. The project aims to enhance T-cell responses and target resistance mechanisms. The project utilizes advanced technologies such as CyTOF, CRISPR, and single-cell sequencing. The project is managed by the University of California, San Francisco, in the Department of Neurosurgery.